Herbst Group’s Biogen BIIB Stock Holding History

Herbst Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,250	Closed	-$474K	–	76
2022 Q2	$474K	Buy	+2,250	New	+$460K	0.37%	62

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Herbst Group's BIIB Position: Q3 2022 in Review

Herbst Group sold out of Biogen (BIIB) in Q3 2022, closing a stake of 2,250 shares — an estimated $474K sold.

Herbst Group first reported a position in BIIB in Q2 2022 and held it in 1 quarter. The position peaked at $474K in Q2 2022. 986 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

Herbst Group reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
Herbst Group sold 2,250 Biogen shares in Q3 2022, an estimated $474K.
Herbst Group first reported a position in Biogen in Q2 2022 and held it in 1 quarter.
Herbst Group's Biogen position peaked at $474K in Q2 2022.
986 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Herbst Group's 13F filing for Q3 2022, filed 14 Nov 2022.